OpenEye Scientific is an industry leader in computational molecular design based on decades of delivering rapid, robust, and scalable software, toolkits, and technology and design services across the drug discovery process. Our scientific approach has focused on visualizing and analyzing the shape and electrostatics of molecular 3D structures to inform and guide the advancement of pharmaceuticals and biotechnology. 

OpenEye recently integrated its applications and toolkits into Orion, the only cloud-native, fully integrated molecular design platform. Combining unlimited computation and storage with powerful tools for data sharing, visualization and analysis in an open development platform, Orion offers unprecedented capabilities for drug discovery and optimization. 

Founded in 1997, OpenEye is a privately held company headquartered in Santa Fe, New Mexico, with offices in Boston, Massachusetts; Cologne, Germany; and Tokyo, Japan. 

For more information, go to http://www.eyesopen.com.

OpenEye, Cadence Molecular Sciences

Anthony Nicholls

Brent Jenkins

Marissa Corley, SHRM-CP

Julia Martinez, CPA, CCIFP

Jharrod LaFon

Jeff Grandy

Geoff Skillman

Bob Tolbert

April S.

The Leadership Team at OpenEye, Cadence Molecular Sciences is responsible for steering the company's strategic direction and overseeing key initiatives in product development, research, sales, and cloud solutions. This collaborative team of senior executives integrates insights from various domains to drive innovation within the Orion platform, ensuring it remains at the forefront of molecular design technology and effectively meets the needs of drug discovery clients worldwide. Their leadership fosters a culture of excellence and collaboration that underpins OpenEye's mission to revolutionize the pharmaceutical and biotechnology industries.

Leadership Team

Scientific Software Development

Leadership Team

About

Team members

Other teams at OpenEye, Cadence Molecular Sciences

Scientific Software Development